HanYu Pharmaceuticals (300199.SZ) signed a cooperation framework agreement for the sale of peptide active pharmaceutical ingredients, with a planned sales amount exceeding 327 million yuan.

Zhichu Financial News APP: Han Yu Pharmaceutical (300199.SZ) announced that in order to expand its overseas business layout and accelerate the commercialization process of GLP-1 raw materials, the company signed a sales cooperation framework agreement for peptide raw materials on May 18, 2026 in Shenzhen with a partner. The planned sales amount is not less than RMB 327 million, accounting for 33.84% of the company's most recently audited operating income.